
    
      Subjects with acne were randomized to one of four treatment groups for twice daily topical
      dosing to the face for 12 weeks. Assessments of acne status were performed at Baseline, Weeks
      2, 4, 8 and 12 and then 4 weeks after the last dose of study drug.
    
  